About
Technology
Issues
FAQ
Links
Official Page
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.